Roche


Roche   link
Location: Basel
Grenzacherstrasse 124, 4070 Basel

Discipline: Pharmacology

Roche is the world’s number 1 in biotech with several biopharmaceuticals on the market. Over half of the compounds in the product pipeline are biopharmaceuticals, enabling Roche to deliver better-targeted therapies.

Health - Pharmacology - Mar 31
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick diagnosis of acute infection allows physicians to decide faster on treatment for transplant patients The EBV panel can be used to rule out other acut
Health - Pharmacology - Mar 30

Evrysdi has proven efficacy in adults, children and babies two months and older, as shown in two pivotal clinical trials Roche is actively engaging with health authorities in the EU to achieve broad and rapid access for people with SMA More than 3,000 patients now treated with Evrysdi in clinical trial, compassionate use and real-world settings

Health - Mar 15

Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample GenMark's ePlex platform delivers rapid and actionable results so clinicians can determine the cause of infection and the most effective treatment, potentially saving lives and alleviating the healthcare burden.

Health - Pharmacology - Mar 11

For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the highest quality diagnostics Access to broader reliable diagnostic solutions helps healthcare communities working to expedite and increase disease elimination programs Roche's Global Access Program provides innovative diagnostic solutions im

Health - Pharmacology - Feb 26

Special approval from German Federal Institute for Drugs and Medical Devices (BfArM) enables home use of a SARS-CoV-2 Rapid Antigen Test using a simple nasal swab The test will be widely available in pharmacies across Germany - Basel, 26 February 2021 - Roche today announced it has been granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) to offer the SARS-CoV-2 Rapid Antigen Test using a simple nasal swab for patient self-testing in Germany.

Pharmacology - Health - Feb 12

Across four studies in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), approximately half of people receiving faricimab could be treated every four months in the first year Approximately three-quarters of people receiving faricimab could be treated every three months or longer in the first year Faricimab sho

Health - Pharmacology - Jan 12

Tecentriq in combination with Avastin provides the longest overall survival seen in a front-line Phase III study in unresectable hepatocellular carcinoma (HCC) Liver cancer is the 6th most common cancer and in 2020 was the third leading cause of cancer deaths worldwide Results to be presented at the 2021 Gastrointestinal Cancers Symposium organi

Health - Pharmacology - Dec 11, 2020

The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection Roche will be able to ramp up to a double-digit million number of tests per month, by early 2021 The test is the latest addition to Roches comprehensive COVID-19 portfolio and can help in the management of patie

Health - Pharmacology - Mar 25

Basel, 25 March 2021 - Roche today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ: GNMK) at a price of $24.05 per share.

Pharmacology - Health - Mar 11

The REMDACTA clinical trial of Actemra/RoActemra plus Veklury did not meet its primary endpoint of improved time to hospital discharge for patients with severe COVID-19 pneumonia or its key secondary endpoints compared to Veklury alone Roche will submit the REMDACTA results to a peer-reviewed journal - Basel, 11 March 2021 - Roche today announce

Health - Pharmacology - Feb 26

CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19   CHMP scientific opinion supports national decision making within EU states on the use of the antibodies before a formal authorisation is granted during a public healt

Health - Pharmacology - Feb 25

FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in the natural course of the disease The FDA approved Evrysdi in August 2020 as the first and only at home SMA treatment with proven efficacy in adult

Health - Pharmacology - Feb 8

FDA BDD acknowledges the importance of GDF-15 testing in identifying eligible cachexic patients with solid tumours to be treated with Pfizer's investigational drug PF-06946860 Unintentional weight loss (cachexia) is a highly prevalent complication of cancer, affecting more than half of all cancer patients worldwide, potentially leading to signif

Health - Pharmacology - Jan 11

UPath HER2 (4B5) image analysis and uPath Dual ISH image analysis aid pathologists in providing faster, more accurate patient diagnoses in breast cancer In combination with the VENTANA DP 200 slide scanner and Roche uPath enterprise software, the new algorithms provide innovative digital pathology solutions to advance personalised healthcare  Nearly 2.1 million new cases of breast cancer are diagnosed worldwide each year.

Health - Pharmacology - Dec 10, 2020

People with muscle-invasive urothelial cancer (MIUC) who had detectable circulating tumour DNA (ctDNA) were more likely to benefit from treatment with adjuvant (after surgery) Tecentriq monotherapy, compared with those without ctDNA The goal of current treatment in people with MIUC is to provide early intervention to reduce the risk of the disea





Website Preview

This site uses cookies and analysis tools to improve the usability of the site. More information. |